Say Hello!
Don’t be shy.

   

News

Image source: European Pharmaceutical Review GW’s ground-breaking medicines development programme recognised for outstanding achievement in innovation with UK’s highest official award for British business Based at Kent Science Park, GW Pharmaceuticals, a world leader in discovering, developing and commercialising regulatory approved cannabis-based medicines, announces that it has...

In4Derm announces a strategic partnership with an innovation-driven NASDAQ listed biotech with a >$200m Option License Agreement for first-in-class BET bromodomain therapeutics pipeline. In4Derm, an innovative biotech company developing novel therapeutics for inflammation and orphan indications, has today announced an Option and Licensing Agreement based around...

BioAscent, the UK's fastest-growing integrated drug discovery CRO, has appointed Dr Angelo Pugliese as Associate Director of In Silico Discovery and Data Analysis to lead the company's computational chemistry service. As well as enhanced computational chemistry capabilities, the medicinal chemistry team has also been strengthened...

BioCity investee, Rinri Therapeutics, a biotechnology company developing a novel stem cell therapy to restore hearing, today announces that it has raised a total of £10 million from existing investors Boehringer Ingelheim Venture Fund (BIVF), UCB Ventures and BioCity alongside the UK Government Future Fund....